首页 | 本学科首页   官方微博 | 高级检索  
     

基于免疫信息学方法设计针对猪急性腹泻综合征冠状病毒S、M及E蛋白的多表位疫苗
引用本文:李世念,刘婉宁,陈亚萍,王金涛. 基于免疫信息学方法设计针对猪急性腹泻综合征冠状病毒S、M及E蛋白的多表位疫苗[J]. 中国畜牧兽医, 2022, 49(3): 1057-1066. DOI: 10.16431/j.cnki.1671-7236.2022.03.028
作者姓名:李世念  刘婉宁  陈亚萍  王金涛
作者单位:黑龙江八一农垦大学动物科技学院, 大庆 163319
基金项目:黑龙江八一农垦大学引进人才科研启动计划(XYB201913)
摘    要:【目的】设计针对猪急性腹泻综合征冠状病毒(Swine acute diarrhea syndrome coronavirus, SADS-CoV) S、M及E蛋白的多表位疫苗。【方法】本研究选用IEDB预测SADS-CoV S、M及E蛋白T淋巴细胞主要组织相容性复合体Ⅰ(MHCⅠ)类分子结合表位;用NetMHCIIpan 4.0 Serve预测T淋巴细胞MHCⅡ类分子结合表位;用Immunomedicine Group、IEDB预测B淋巴细胞表位。将各个服务器预测结果筛选出重叠表位区域作为优势表位,运用IEDB、AllerTOP v 2.0 Servers筛选出高保守性、非致敏性的优势表位区域,通过柔性linker串联成多表位疫苗。对构建的多表位疫苗进行抗原性、理化性质、N-糖基化位点、二级结构和三级结构预测。使用分子对接评估多表位疫苗与免疫受体的结合能力,最后进行基因克隆。【结果】经筛选后的高保守性、非致敏性优势表位构建的多表位疫苗相对分子质量为35.30 ku,为稳定亲水蛋白,具有良好的抗原性,存在1个N-糖基化位点,在二级结构中α-螺旋、β-折叠、无规则卷曲和β-转角分别占22....

关 键 词:猪急性腹泻综合征冠状病毒(SADS-CoV)  结构蛋白  免疫信息学方法  T淋巴细胞表位  B淋巴细胞表位  多表位疫苗
收稿时间:2021-08-24

Design of Multi Epitope Vaccine Against Swine Acute Diarrhea Syndrome Coronavirus S,M and E Proteins Based on Immunoinformatics Methods
LI Shinian,LIU Wanning,CHEN Yaping,WANG Jintao. Design of Multi Epitope Vaccine Against Swine Acute Diarrhea Syndrome Coronavirus S,M and E Proteins Based on Immunoinformatics Methods[J]. China Animal Husbandry & Veterinary Medicine, 2022, 49(3): 1057-1066. DOI: 10.16431/j.cnki.1671-7236.2022.03.028
Authors:LI Shinian  LIU Wanning  CHEN Yaping  WANG Jintao
Affiliation:College of Animal Science and Veterinary Medicine, Heilongjiang Bayi Agricultural University, Daqing 163319, China
Abstract:【Objective】 The study was aimed to design a multi-epitope vaccine against Swine acute diarrhea syndrome coronavirus (SADS-CoV) S, M and E proteins.【Method】 IEDB server was used to predict the MHC class Ⅰ molecular binding epitopes of SADS-CoV S protein, M protein and E proteins of T lymphocytes.T lymphocyte MHC class Ⅱ molecule binding epitopes were predicted by NetMHCIIpan 4.0 Serve.Immunomedicine Group and IEDB server were used to predicted B lymphocyte epitopes.The overlapping epitope regions were selected as the dominant epitopes from the prediction results of each server, and the highly conservative and non-sensitizing dominant epitope regions were selected by using IEDB and AllerTOP v 2.0 servers, which were connected in series into a multi epitope vaccine through a flexible linker.The antigenicity, physicochemical properties, N-glycosylation sites, secondary and tertiary structures of the constructed multi-epitope vaccine were evaluated.The binding capacity of multi-epitope vaccines to immune receptors was evaluated by molecular docking and silico cloning was carried out.【Result】 The results showed that the multi-epitope vaccine constructed with highly conservative and non-sensitizing dominant epitopes had a relative molecular weight of 35.30 ku.It was a stable hydrophilic protein with good antigenicity.There was one N-glycosylation site, and the alpha helix, beta sheet, random coil and beta turn were 22.11%, 20.35%, 50.88% and 6.67% in the secondary structure, respectively.Ramachandran mapping of tertiary structure found that the residue base in the dominant region accounted for 90.00%.After refinement, the residue base in the dominant region increased to 91.92%.Mapping of prominent epitopes of tertiary structure also proved that the multi-epitope vaccine had good immunogenicity, and molecular docking showed that the multi epitope vaccine had high affinity with TLR3.Finally, codon optimization, reverse translation and silico cloning ensure the efficient and stable expression of the designed multi epitope vaccine in E.coli K12 expression system.【Conclusion】 The constructed multi-epitope vaccine might effectively express and induce strong T-cell and B-cell immune responses.This study provided a new method for the design of SADS-CoV multi-epitope vaccine, and provided theoretical basis and data support for the research and development of SADS-CoV multi-epitope vaccine.
Keywords:Swine acute diarrhea syndrome coronavirus (SADS-CoV)  structural protein  immunoinformatics method  T lymphocyte epitope  B lymphocyte epitope  multi-epitope vaccine  
点击此处可从《中国畜牧兽医》浏览原始摘要信息
点击此处可从《中国畜牧兽医》下载全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号